Swiss Life Sciences Stock News

UBS Group subsidiary fined $125 million by multiple U.S. regulators for repeated anti money laundering violations. Penalties follow admissions that the bank failed to properly monitor foreign currency wire transfers and file suspicious activity reports. The settlement ranks among the larger recent anti money laundering cases involving a global financial institution. For investors tracking UBS Group, ticker SWX:UBSG, this enforcement action arrives while the stock trades around CHF42.55. The...

Amid a week of mixed performances in major global indices, driven by central bank decisions and geopolitical tensions, investors are keenly observing market dynamics to identify potential opportunities. In such an environment, stocks estimated to be trading below their fair value can offer attractive prospects for those looking to capitalize on market inefficiencies.

As the European markets experience a notable upswing, with the STOXX Europe 600 Index reaching new highs and key indices like Germany’s DAX and France’s CAC 40 showing significant gains, investors are increasingly focused on companies that not only demonstrate robust growth potential but also have substantial insider ownership. In this context, stocks where insiders hold significant stakes can be appealing as they suggest confidence from those closest to the business, aligning management's...

Half year earnings put Forbo Holding stock under closer scrutiny Forbo Holding (SWX:FORN) has drawn fresh attention after reporting half year 2026 results that showed marginally lower sales and net income compared to the prior year period, prompting investors to reassess the stock. See our latest analysis for Forbo Holding. The half year figures appear to have acted as a catalyst for Forbo Holding, with the share price delivering a 24.1% 30 day share price return and a 24.3% 90 day share...

Why ALSO Holding Stock Is Back In Focus After H1 2026 Earnings ALSO Holding (SWX:ALSN) is drawing fresh attention after its H1 2026 earnings announcement on 21 July, which outlined higher sales, net income and earnings per share compared with the same period last year. See our latest analysis for ALSO Holding. The H1 2026 results arrived after a period where ALSO Holding’s share price climbed 20.2% over the past 90 days to CHF192.8, while the 1 year total shareholder return declined 18.97%...

Kuehne + Nagel International (SWX:KNIN) released mixed results for the second quarter and first half of 2026, giving investors fresh detail on how the logistics group is performing across different reporting periods. See our latest analysis for Kuehne + Nagel International. Over the past year Kuehne + Nagel International has combined a 12.59% 90 day share price return with a 28.07% 1 year total shareholder return, suggesting improving momentum even though the 3 and 5 year total shareholder...

Sulzer (SWX:SUN) drew fresh investor attention on 28 July 2026 after reporting half year 2026 results, with net income and earnings per share higher despite lower sales compared with the prior period. See our latest analysis for Sulzer. Against this earnings backdrop, Sulzer’s share price has moved to CHF146.40, with a 1 month share price return of 10.08% but a year to date share price return that is down 3.56%. The 3 year total shareholder return of 87.63% and 5 year total shareholder return...

Novartis (SWX:NOVN) is back in focus after the US Food and Drug Administration approved an expanded use of Pluvicto in combination with androgen receptor pathway inhibitors for PSMA-positive metastatic hormone-sensitive prostate cancer. See our latest analysis for Novartis. Novartis shares have been firming over 2026, with a 16.68% year to date share price return and a 38.50% total shareholder return over one year, as investors weigh the expanded Pluvicto approval alongside recent earnings,...

Investors in Zehnder Group AG ( VTX:ZEHN ) had a good week, as its shares rose 8.3% to close at CHF67.70 following the...

Clariant came into this earnings print trading at CHF9.15 after a strong run over the past month, yet the latest half-year numbers still tell a turnaround story in progress rather than one already secured. The stock looks inexpensive on simple sales multiples, but the headline from H1 2026 is that profitability remains fragile. Group EBITDA before exceptionals held at a mid to high teens margin, while the company remained loss making over the last twelve months and net debt edged higher to...

Interroll Holding stock has been treading water in recent weeks, with a small gain of just over 3% in the past month and a double digit slide over the past quarter. The earnings headline that cuts through the noise is margin pressure. First half 2026 delivered a 10% EBIT margin and net profit of CHF 19.8m, slightly softer despite solid intralogistics demand. The market sees a high quality balance sheet, a trailing P/E of 20.2x and analyst forecasts that point to faster earnings growth than...

It's been a pretty great week for Autoneum Holding AG ( VTX:AUTN ) shareholders, with its shares surging 20% to CHF131...

Shareholders appeared unconcerned with APG|SGA SA's ( VTX:APGN ) lackluster earnings report last week. Our analysis...

The stock was sluggish on the back of CALIDA Holding AG's ( VTX:CALN ) recent earnings report. Our analysis suggests...

Holcim stock closed at CHF73.34 on the day of the results and has drifted slightly lower over the past week. The market reaction looks muted for a company that just reported mid single digit organic net sales growth and double digit organic recurring EBIT growth in the first half. The real story is not today’s small move in the share price. It is how investors weigh that earnings power against a P/E above 100x that is anchored in a year affected by a CHF1.3b one off loss. Is Holcim a genuine...

Avolta closed at CHF48.34 after the H1 2026 release, roughly flat over the past week and still down about 11% over the past month. The stock is trading on a rich P/E of 31.9x, yet the latest half shows the earnings story that has kept investors engaged. Net income reached CHF35.0m with basic earnings per share of CHF0.25, and management kept the focus on cash with equity free cash flow of €207m and leverage around 2.07x. The key issue for investors is whether that earnings and cash mix...

Bachem Holding walked into this earnings season with a growth-stock label and a rich P/E of 37.6x, yet the share price has drifted down about 3% over the past month to CHF 74.80. Today's H1 numbers put the spotlight on something less glamorous and more important for you as an investor. The peptide and oligonucleotide specialist is pouring money into capacity, with H1 capital expenditure of CHF 148m and EBITDA margin sitting at 25.4%. The key question is whether this heavy build-out and margin...

INFICON Holding stock closed at CHF162.60 on 31 July, roughly flat over the past week after a choppy few months. The market reaction looks cautious. The earnings story is not. H1 2026 showed clear profit recovery in a capital intensive semiconductor equipment world, with basic earnings per share at US$2.27 and trailing net profit margin at 13.5%. The immediate price move tells you how traders felt today. The multi year forecasts and the valuation you are paying for that recovery are what...

Why Kardex Holding Stock Is Back In Focus After Its Half Year 2026 Results Kardex Holding (SWX:KARN) is back on investor radars after its half year 2026 update, which combined strong growth in bookings and order backlog with a 40% EBIT decline and a profit warning. The company reported half year sales of €440.5 million compared with €415.7 million a year earlier, while net income moved from €36.2 million to €22.6 million and basic EPS from €4.69 to €2.93. See our latest analysis for Kardex...

Idorsia closed at CHF6.12, roughly flat over the past week but still carrying a strong 90 day rebound in the share price. The market has been treating this as a recovery story. The Q2 earnings headline pulls investors back to the balance sheet. The company is still loss making and carries negative shareholders’ equity, and yet trades on a price to sales ratio of 7.8x, below both the European biotech average and key peers. The central question now is whether the liquidity moves and earnings...

Zehnder Group stock closed at CHF67.70 on Friday after a steady run over the past month. Yet the real story sits in the income statement rather than the ticker. The latest half year numbers put a bright spotlight on profitability. Net profit margin now stands at 6% compared with 2.4% a year earlier and earnings over the past 12 months are sharply higher. That kind of margin rebuild matters more than a single day’s move. For long term investors in building ventilation and climate systems, the...

Bucher Industries stock closed at CHF316 after a choppy week that left shares down about 4.5% over seven days, even as the latest half year numbers landed. The market focused on softer profit metrics more than the headline revenue figure of CHF1,471.4m for H1 2026. Net income of CHF87.5m and basic earnings per share of CHF8.90 point to a profit squeeze that matters far more than a single day price move. For long term holders, the key question now is how this margin pressure fits with the...

Sika AG ( VTX:SIKA ) investors will be delighted, with the company turning in some strong numbers with its latest...

It's been a good week for Sulzer AG ( VTX:SUN ) shareholders, because the company has just released its latest...